PLRX

Pliant Therapeutics Inc

PLRX.US pliantrx.com + Research + Basket
CIK 0001746473
Employees 49
Phone 650 481 6770
Fiscal year end December
IPO Jun 03, 2020
Address 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
0.88
-0.01 (-0.72%)
USD · NASDAQ
52-week range
0.83
1.82
Trading at 5% of the 52-week range
Market Cap
55.10M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
2.37
Div. Yield
N/A
% Institutions
78.05%
% Insiders
2.23%

1 Year

-50.0%

3 Year

-93.6%

10 Year

-95.8%
Description

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Actions

Add an action for PLRX.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Bernard Jozef Coulie M.B.A., M.D., Ph.D. President, CEO & Director 1966
Dr. Keith Lamont Cummings M.B.A., M.D. Chief Financial Officer 1977
Ms. Minnie Kuo Chief Operating Officer 1981
Dr. Rik Derynck Ph.D. Scientific Founder & Member of Scientific Advisory Board NA
Mr. Dean Sheppard M.D. Scientific Founder & Member of Scientific Advisory Board NA
Mr. Bill DeGrado Ph.D. Scientific Founder NA
Mr. Hal Chapman M.D. Scientific Founder & Member of Scientific Advisory Board NA
Ms. Delphine Imbert Ph.D. Chief Technical Officer NA
Mr. Christopher S. Keenan Vice President of Investor Relations & Corporate Communications NA
Ms. Lily Cheung Chief Human Resources Officer 1973

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jan 20, 2026 Bernard Coulie N/A Sale 89.38K $1.28 $114.40K SEC
Jan 20, 2026 Minnie Kuo N/A Sale 6.92K $1.28 $8.85K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
TANG CAPITAL MANAGEMENT LLC 6.14M Jun 30, 2026 9.92% $0.32 -0.03%
ADAR1 Capital Management LLC 5.51M Jun 30, 2026 8.90% $0.29 113.13%
Vanguard Capital Management, LLC 2.44M Jun 30, 2026 3.94% $0.00 4.15%
Acadian Asset Management LLC 2.42M Jun 30, 2026 3.90% $0.00 0.00%
Two Sigma Investments LLC 2.26M Jun 30, 2026 3.65% $0.00 0.43%
Citadel Advisors Llc 2.14M Jun 30, 2026 3.46% $0.00 -33.61%
Renaissance Technologies Corp 2.05M Jun 30, 2026 3.31% $0.00 10.63%
Monaco Asset Management 1.94M Jun 30, 2026 3.13% $0.18 0.00%
Lynx1 Capital Management, LP 1.80M Jun 30, 2026 2.90% $0.24 0.00%
BML Capital Management LLC 1.55M Jun 30, 2026 2.50% $1.00 0.00%
Prosight Management, LP 1.37M Jun 30, 2026 2.21% $0.27 -17.83%
Peapod Lane Capital LLC 1.31M Jun 30, 2026 2.11% $1.01 1.59%
Woodline Partners LP 1.30M Jun 30, 2026 2.09% $0.00 -22.22%
BlackRock Inc 1.15M Jun 30, 2026 1.86% $0.00 5.00%
Ikarian Capital, LLC 1.00M Jun 30, 2026 1.61% $0.12 0.00%
Eversept Partners, LP 891.43K Jun 30, 2026 1.44% $0.05 0.00%
Marshall Wace Asset Management Ltd 835.12K Jun 30, 2026 1.35% $0.00 -16.15%
Redmile Group, LLC 772.13K Jun 30, 2026 1.25% $0.06 0.00%
JPMorgan Chase & Co 681.65K Jun 30, 2026 1.10% $0.00 -20.91%
Jacobs Levy Equity Management, Inc. 643.12K Jun 30, 2026 1.04% $0.00 -10.50%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.75M 2.82% ▲ 0.00% Sep 30, 2026
2 Bridgeway Ultra-Small Company 471.33K 0.76% ▲ 0.00% Jun 30, 2026
3 Sun Life Global Mid Cap Fund I 373.60K 0.60% ▲ 0.00% Jul 31, 2026
4 Fidelity Extended Market Index 350.60K 0.57% ▲ 8.79% Aug 31, 2026
5 iShares Micro-Cap ETF 197.09K 0.32% ▼ 0.68% Sep 30, 2026
6 Vanguard Health Care ETF 155.69K 0.25% ▲ 0.11% Sep 30, 2026
7 Goldman Sachs Absolute Ret Trckr Instl 96.07K 0.16% ▲ 519.98% Jun 30, 2026
8 Fidelity Total Market Index 94.75K 0.15% ▲ 0.00% Aug 31, 2026
9 EA Bridgeway Ultra-Small Company Mkt ETF 81.15K 0.13% ▲ 0.00% Sep 30, 2026
10 Fidelity Series Total Market Index 79.91K 0.13% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $55.10M
EBITDA: $-89.87M
Book Value: $2.37
Earnings/Share: $-1.59
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -23.27%
ROE (TTM): -50.29%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $-77.34M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 61.92M
Shares Float: 55.03M
% Insiders: 2.23%
% Institutions: 78.05%
Short % Float: 7.66%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-1.70M
Gross Profit
subtotal
$-1.70M
SG&A
adjust
$-47.22M
R&D
adjust
$-109.16M
Operating Income
subtotal
$-150.07M
Other / Non-Operating Items
adjust
$729.00K
Net Income
subtotal
$-149.34M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PLRX.US!